Intensified therapy improves outcomes for childhood B-cell acute lymphoblastic leukemia subgroup
Intensifying therapy significantly improved OS and reduced the risk for relapse among children with childhood B-cell acute lymphoblastic leukemia and IKZF1 deletion, study data showed.